Does DUPILUMAB Cause Injection site dryness? 320 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 320 reports of Injection site dryness have been filed in association with DUPILUMAB (Dupixent). This represents 0.1% of all adverse event reports for DUPILUMAB.
320
Reports of Injection site dryness with DUPILUMAB
0.1%
of all DUPILUMAB reports
0
Deaths
7
Hospitalizations
How Dangerous Is Injection site dryness From DUPILUMAB?
Of the 320 reports, 7 (2.2%) required hospitalization.
Is Injection site dryness Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DUPILUMAB. However, 320 reports have been filed with the FAERS database.
What Other Side Effects Does DUPILUMAB Cause?
Pruritus (44,279)
Dermatitis atopic (33,670)
Product use in unapproved indication (33,452)
Rash (30,895)
Injection site pain (27,799)
Drug ineffective (23,712)
Dry skin (20,239)
Eczema (20,020)
Product dose omission issue (18,189)
Condition aggravated (16,459)
What Other Drugs Cause Injection site dryness?
ETANERCEPT (37)
ADALIMUMAB (31)
SARILUMAB (29)
BELIMUMAB (21)
PEGINTERFERON BETA-1A (21)
TREPROSTINIL (16)
ALIROCUMAB (14)
GLATIRAMER (13)
INTERFERON BETA-1A (13)
TIRZEPATIDE (12)
Which DUPILUMAB Alternatives Have Lower Injection site dryness Risk?
DUPILUMAB vs DURAGESIC
DUPILUMAB vs DUROGESIC
DUPILUMAB vs DUROTEP MT
DUPILUMAB vs DURVALUMAB
DUPILUMAB vs DUTASTERIDE